TAG's 2020 Pipeline Report: TB Chapters Released

TAG’s 2020 Pipeline Report: TB Chapters Released

TAG is pleased to launch newly available tuberculosis (TB) chapters of our 2020 Pipeline Report . This landmark annual publication reviews progress in research and development for TB diagnostic, preventive, and treatment innovations.

In the following 2020 Pipeline Report chapters, available online via easily downloadable PDFs, you will find:

Tuberculosis Diagnostics by David Branigan
Detailed information on the range of new diagnostic tools for TB and DR-TB currently in the pipeline, including how they are expected to address the shortcomings of existing tools and move closer toward meeting WHO and FIND target criteria; the science and technology behind these new tools and considerations for implementing them in health care settings; and ways to take action to promote TB diagnostics research and access.

Tuberculosis Vaccines by Mike Frick
Reviews of notable advances in the clinical development of new TB vaccines, including an inventory of recently completed, ongoing, and planned clinical trials, as well as in-depth discussions of studies of BCG revaccination, M72/AS01E, ID93/GLA-SE, among other TB vaccine candidates.

Tuberculosis Preventive Therapy by Mike Frick
An inventory of recently completed, ongoing, and planned clinical trials of TB preventive therapy (TPT), including a detailed discussion of recent studies of the 3HP regimen in people living with HIV and pregnant women and an overview of efforts to develop long-acting formulations of TPT.

Tuberculosis Treatment by Lindsay McKenna
Summaries of influential treatment studies and data sets, including results from two large phase III trials to evaluate four-month regimens for treating drug-sensitive TB; and information on new drugs and regimens in clinical development for TB as well as the initiatives and approaches expected to drive them forward.

From diagnosis to prevention to treatment, this is a truly exciting moment for TB research with plenty of promising studies and developments worthy of close attention. We hope you find this resource useful in your scientific, policy, and advocacy work. And please feel free to share it widely!

Contact Us: Treatment Action Group, 90 Broad Street, Suite 2503, New York, New York 10004, 212-253-7922. communications@treatmentactiongroup.org. TAG fights for life-saving information and care for people living with, and at risk for, HIV, TB, and HCV. Please consider supporting this work by making a donation today.